Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASN008 in mild to moderate atopic dermatitis
NCT05870865Phase 2Completed
- Sponsor
- Formation Bio
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Olisutrigine bromide in atopic dermatitis (AD), sponsored by Formation Bio. Started May 2023; status: completed.
02
Drugs
Olisutrigine bromide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05870865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870865.